Investor Intelligence
9 Longevity Investors in Europe
Investors financing European longevity across aging biology, preventive health, continuous monitoring and technologies designed to extend healthy lifespan.
- Longevity
- Preventive Health
- Aging Biology
- Europe
- Seed
- Series A
Longevity capital in Europe now spans more than one investment model. Specialist biotech funds are backing therapies that target mechanisms of aging, while healthtech investors are financing prevention, continuous monitoring and personalized platforms that aim to intervene earlier in chronic disease. The result is a market stretching from laboratory-stage biology to consumer-facing health infrastructure.
DealBio selected 9 investors with evidenced relevance to European longevity and preventive health, using current investor research, financing precedents and public verification where needed.
Apollo Health Ventures
Specialist health investor and venture builder focused on companies addressing aging biology, chronic disease and healthy lifespan.
- Stage
- Seed · Series A
- Sector / Focus
- Longevity · Aging biology · Therapeutics
- Investment markets
- Europe · United States
- Investor type
- VC / Venture builder
Healthspan Capital
Early-stage fund dedicated to longevity biotechnology and regenerative medicine.
- Stage
- Pre-seed · Seed · Series A
- Sector / Focus
- Longevity biotech · Regenerative medicine · Aging biology
- Investment markets
- Europe · United States
- Investor type
- VC
LongeVC
Early-stage venture firm investing specifically in biotechnology and longevity-focused companies.
- Stage
- Seed · Series A
- Sector / Focus
- Longevity · Biotech · Diagnostics and prevention
- Investment markets
- Europe · United States · Global
- Investor type
- VC
Infinita VC
Early-stage investor backing biotechnology and other technologies where regulatory or infrastructure constraints create room for new models.
- Stage
- Seed
- Sector / Focus
- Biotechnology · Longevity · Frontier technology
- Investment markets
- Europe · Global
- Investor type
- VC
VitaDAO
Community-governed organization funding longevity research and early biotechnology projects.
- Stage
- Pre-seed · Seed
- Sector / Focus
- Longevity research · Biotech · Drug discovery
- Investment markets
- Global · Europe
- Investor type
- DAO / Investment community
Calm/Storm
European early-stage healthtech investor focused on founders building new models of healthcare and prevention.
- Stage
- Pre-seed · Seed · Series A
- Sector / Focus
- Preventive health · Personalized health · Longevity
- Investment markets
- Europe
- Investor type
- VC
Kfund
European venture firm investing from pre-seed through later early-stage rounds across technology, including an expanding healthtech thesis.
- Stage
- Pre-seed · Seed · Series A · Series B
- Sector / Focus
- Preventive health · Healthtech · Wearables
- Investment markets
- Europe
- Investor type
- VC
GoHub Ventures
European early-stage investor backing software and technology companies with defensible data and infrastructure advantages.
- Stage
- Seed · Series A
- Sector / Focus
- Preventive health · Chronic care · Healthcare AI
- Investment markets
- Europe
- Investor type
- VC
Pareto Holdings
Private investment firm backing technology, healthcare and longevity companies at early stages.
- Stage
- Seed · Series A
- Sector / Focus
- Longevity · Preventive health · Biotech
- Investment markets
- Europe · United States
- Investor type
- Investment firm
Methodology
DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.